| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |